However, in the two transplanted NPCTKO GBMs where some malignant cells co-expressed Tbx18-driving GFP, these cells mostly aggregated as clones and expressed SOX2 and/or OLIG2, but did not express ACTA2, indicating their GBM cell identity. This evidence concerns the gene SOX2 and glioblastoma.